New Findings in World Health Organization Described by C. Anyakora and Co-Researchers (Cost benefit of investment on quality in pharmaceutical…
New Findings in World Health Organization Described by C. Anyakora and Co-Researchers (Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer)
By a
Our news journalists obtained a quote from the research, "However, most of the local pharmaceutical manufacturing companies may be deterred from investing in quality because of many reasons, ranging from financial constraints to technical capacity. This paper primarily evaluates benefits against the cost of investing in GMP, using a Nigerian pharmaceutical company,
According to the news editors, the research concluded: "Local pharmaceutical companies should be encouraged to key into development opportunities available for pharmaceutical companies in
For more information on this research see: Cost benefit of investment on quality in pharmaceutical manufacturing: WHO GMP pre- and post-certification of a Nigerian pharmaceutical manufacturer.
Our news journalists report that additional information may be obtained by contacting C. Anyakora,
Keywords for this news article include:
Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2017, NewsRx LLC
Physicians’ Reciprocal Insurers Completes Transition to Self-Management with Installation of PRIMMA as Attorney-in-Fact
Woman tried to get FEMA assistance after Irma but someone had already stolen her identity
Advisor News
Annuity News
Health/Employee Benefits News
Life Insurance News